171 related articles for article (PubMed ID: 17151714)
1. Utilisation of intravenous immunoglobulin in New Zealand: a clinical audit.
Hutchinson D; Flanagan P; Charlewood R; Mitchell T
N Z Med J; 2006 Dec; 119(1246):U2340. PubMed ID: 17151714
[TBL] [Abstract][Full Text] [Related]
2. How intravenous immunoglobulin is used in clinical practice: audits of two Sydney teaching hospitals.
Lin MW; Kirkpatrick PE; Riminton DS
Intern Med J; 2007 May; 37(5):308-14. PubMed ID: 17504278
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin therapy for neurological disorders.
Harkins C; Hammond-Tooke G; Faed J
N Z Med J; 2009 Oct; 122(1305):41-6. PubMed ID: 19966877
[TBL] [Abstract][Full Text] [Related]
4. Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995-2000.
Pendergrast JM; Sher GD; Callum JL
Vox Sang; 2005 Oct; 89(3):150-60. PubMed ID: 16146507
[TBL] [Abstract][Full Text] [Related]
5. Survey of clinical echocardiography in New Zealand (SCANZ).
Bridgman PG; Ashrafi AN; Mann S; Whalley GA;
N Z Med J; 2008 Feb; 121(1269):34-44. PubMed ID: 18278080
[TBL] [Abstract][Full Text] [Related]
6. Use of intravenous immunoglobulin G (IVIG).
Looney RJ; Huggins J
Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
[TBL] [Abstract][Full Text] [Related]
7. The case for a national service for primary immune deficiency disorders in New Zealand.
Ameratunga R; Steele R; Jordan A; Preece K; Barker R; Brewerton M; Lindsay K; Sinclair J; Storey P; Woon ST
N Z Med J; 2016 Jun; 129(1436):75-90. PubMed ID: 27355232
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immune globulin use in Canada.
Hanna K; Poulin-Costello M; Preston M; Maresky N
Can J Clin Pharmacol; 2003; 10(1):11-6. PubMed ID: 12687032
[TBL] [Abstract][Full Text] [Related]
9. Trends in hospital bed utilisation in New Zealand 1989 to 2006: more or less beds in the future?
Malcolm L
N Z Med J; 2007 Oct; 120(1264):U2772. PubMed ID: 17972981
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group.
Constantine MM; Thomas W; Whitman L; Kahwash E; Dolan S; Smith S; Caudle CJ; Burton E; Anderson DR;
Transfusion; 2007 Nov; 47(11):2072-80. PubMed ID: 17958537
[TBL] [Abstract][Full Text] [Related]
11. Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres.
Shih AW; Jamula E; Diep C; Lin Y; Armali C; Heddle NM; Traore A; Doherty J; Shah N; Hillis CM
Transfus Med; 2017 Apr; 27(2):122-131. PubMed ID: 28144996
[TBL] [Abstract][Full Text] [Related]
12. Acute rheumatic fever in the Waikato District Health Board region of New Zealand: 1998-2004.
Atatoa-Carr P; Bell A; Lennon DR
N Z Med J; 2008 Nov; 121(1285):96-105. PubMed ID: 19079442
[TBL] [Abstract][Full Text] [Related]
13. Clinical usage of intravenous immunoglobulins in Auckland.
Lee YC; Woodfield DG; Douglas R
N Z Med J; 1998 Feb; 111(1060):48-50. PubMed ID: 9539915
[TBL] [Abstract][Full Text] [Related]
14. Inpatient paediatric use of intravenous immunoglobulin at an academic medical centre.
Dashti-Khavidaki S; Khalili H; Farshadi F; Aghamohammadi A; Movahedi M; Hajibabaei M
Singapore Med J; 2008 Feb; 49(2):147-9. PubMed ID: 18301844
[TBL] [Abstract][Full Text] [Related]
15. Use of fresh-frozen plasma at Royal Darwin Hospital: a retrospective audit.
Moylan S; Szabo F; Scott H; Kwok G
Intern Med J; 2008 Sep; 38(9):686-91. PubMed ID: 19143886
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia.
Alangari AA; Abutaleb MH; Albarraq AA; Al-Dhowailie AA
Saudi Med J; 2008 Jul; 29(7):975-9. PubMed ID: 18626524
[TBL] [Abstract][Full Text] [Related]
17. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
Léger JM; Viala K; Maisonobe T; Bouche P
Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
19. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
Lewandowicz-Uszyńska A; Jankowski A
Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
[TBL] [Abstract][Full Text] [Related]
20. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
